Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapa...
Q1 2026
May 7, 2026
FY 2025
Mar 31, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 14, 2025